← Back to Search

Project PEER: Understanding the Lung Cancer Patient ExperiEnce (PEER Trial)

Verified Trial
N/A
Recruiting
Led By Upal Basu Roy, PhD, MPH
Research Sponsored by LUNGevity Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults with self-reported lung cancer diagnosis or caregiver of someone with a self-reported lung cancer diagnosis (patient has to be alive)
Ability to read and answer questions in English
Timeline
Screening 3 weeks
Treatment 12 months
Follow Up from baseline and assessed monthly up to end of study (up to approximately 12months)
Awards & highlights

PEER Trial Summary

This trial seeks to learn how treatments for lung cancer affect quality of life. Join by emailing study team to get access to the study website & get an e-gift card each month for 12 months for completing surveys. #LungCancer #Participation #ResearchStudy

Who is the study for?
This study is for individuals with lung cancer, including those with a specific type called lung carcinoid tumor, as well as their caregivers. Participants should be willing to share their experiences through monthly online surveys over the course of a year.Check my eligibility
What is being tested?
There are no medical treatments being tested in this trial. Instead, participants will complete online surveys designed to gather information on how living with lung cancer affects quality of life from both patients' and caregivers' perspectives.See study design
What are the potential side effects?
Since there are no medical interventions involved in this study, there are no side effects associated with treatment. The main consideration for participants is the time commitment required to complete the monthly surveys.

PEER Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

PEER Trial Timeline

Screening ~ 3 weeks
Treatment ~ 12 months
Follow Up ~from baseline and assessed monthly up to end of study (up to approximately 12months)
This trial's timeline: 3 weeks for screening, 12 months for treatment, and from baseline and assessed monthly up to end of study (up to approximately 12months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Explore guideline concordant care
Explore impacts of different classes of therapies
Explore patient-reported functioning, symptoms, side effects and overall quality of life
Other outcome measures
Impact of the pandemic on access to treatment

PEER Trial Design

2Treatment groups
Experimental Treatment
Group I: PatientsExperimental Treatment1 Intervention
Individuals who have been diagnosed with lung cancer. Individuals with all stages of lung cancer and individuals who have reached no evidence of disease (NED).
Group II: CaregiversExperimental Treatment1 Intervention
Family and friends who provide care for someone who has been diagnosed with lung cancer

Find a Location

Who is running the clinical trial?

NovartisIndustry Sponsor
1,611 Previous Clinical Trials
2,719,735 Total Patients Enrolled
LUNGevity FoundationLead Sponsor
7 Previous Clinical Trials
346 Total Patients Enrolled
AmgenIndustry Sponsor
1,371 Previous Clinical Trials
1,376,918 Total Patients Enrolled

Media Library

Online Study Clinical Trial Eligibility Overview. Trial Name: NCT05826756 — N/A
Lung Cancer Research Study Groups: Patients, Caregivers
Lung Cancer Clinical Trial 2023: Online Study Highlights & Side Effects. Trial Name: NCT05826756 — N/A
Online Study 2023 Treatment Timeline for Medical Study. Trial Name: NCT05826756 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many sites are engaged in conducting this experiment?

"Currently, 11 locations are hosting this clinical trial. The sites are located in Dallas, Stockton and Detroit as well as 8 other cities. To reduce travel-related costs and hassle, it is suggested that you choose the nearest site for your participation."

Answered by AI

Are there any opportunities for new participants in this medical trial?

"Affirmative. Clinicaltrials.gov indicates that this clinical trial, first listed on August 15th 2020, is actively recruiting candidates for the study. 1300 participants are needed to be recruited from 11 distinct sites."

Answered by AI

What is the approximate number of individuals who are currently participating in this trial?

"The sponsor of the study, Novartis, requires 1300 patients with compatible characteristics to conduct it at various locations. These include Dallas in Texas and Stockton in California."

Answered by AI

Who else is applying?

What state do they live in?
Indiana
Texas
Florida
Other
What site did they apply to?
Fort Wayne, IN
New York, NY
Dallas, TX
Other
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

Why did patients apply to this trial?

Because I just reacquainted with Susan after 30 yrs and we have things we'd like to do before I leave.
PatientReceived 1 prior treatment

How responsive is this trial?

Typically responds via
Email
Phone Call
Average response time
  • < 2 Days
Most responsive sites:
  1. New York, NY: < 24 hours
  2. Stockton, CA: < 24 hours
  3. Greenville, NC: < 24 hours
Recent research and studies
clinicaltrials.govStudy
Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
2020. "Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05826756.
All > Lung Cancer Dallas > Honolulu
~178 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top